
CMB connects fundamental molecular biology with clinical practice and prioritizes research that moves discoveries from bench to bedside.
Its core themes include translational medicine, molecular and cellular biology, clinical biochemistry, genomics and epigenetics, proteomics and metabolomics, microbiome research, molecular oncology, neurobiology, biomarker discovery, drug discovery and resistance, gene and cell therapy, precision medicine, and immunology.
https://editorypress.uz/journal/clinical-molecular-biomedicine
imtiyaz.hassan@gmail.com
hassanlab@jmi.ac.in
https://hassanlab.in
Medicine & Health Sciences.
Core themes include genomics and epigenetics, proteomics and metabolomics, molecular and cellular biology, translational oncology, molecular neurobiology, biomarker discovery, precision medicine, microbiome research, gene and cell therapy, drug resistance, and clinically relevant molecular diagnostics.
Electronic ISSN: 2345-2985
Print ISSN: Not specified on the public page
Public cite score and impact factor values were not listed on the source journal page.
CMB articles are published in an immediate open-access format.
The public journal policy states that article processing charges are FREE.
CMB emphasizes rigorous, fair, and timely peer review beginning with initial editorial suitability screening.
Suitable submissions typically proceed to single anonymized review by at least two independent experts before the final editorial decision.

© 2025 EditoryPress. Public Clinical & Molecular Biomedicine.
© 2026 EditoryPress. All rights reserved.